MAIA Biotechnology, Inc.
AMEX:MAIABiotechnology
+$0.05 today
- Market cap
- $80.28M
- Beta
- 0.24
- P/E (TTM)
- -1.8
- EPS (TTM)
- -$0.76
Volume 2.25M
Average 0.78M
MAIA Common Stock
The par or stated value of issued common shares, plus paid-in capital where reported together.
MAIA Biotechnology, Inc.AMEX: MAIA
Common Stock · Q1 FY2026 · quarter ended Mar 2026
Common stock rises 105.1% from a year ago
Common stock stood at $6.07K at the end of Q1 FY2026, up 105.1% from a year earlier and up 57.1% from the prior quarter. Over 3 fiscal years it compounded at +52.2% a year.
Context
- Common stock amounted to 0.0% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
- Common stock increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether common stock keeps rising in the next quarterly balance sheet after a +105.1% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Common Stock history
USD · from the balance sheet
- Latest · FY2025
- 3.86K USD
- Year-over-year change
- +47.7%
- 4-year CAGR
- +50.2%
| Period | Period end | Common Stock | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 3.86K | +47.7% |
| FY2024 | 2024-12-31 | 2.62K | +54.0% |
| FY2023 | 2023-12-31 | 1.7K | +55.0% |
| FY2022 | 2022-12-31 | 1.1K | +44.6% |
| FY2021 | 2021-12-31 | 758 | — |
Common Stock vs competitors
How MAIA compares with its peers on the latest reported figures
- MAIA's Mar 2026 common stock of $6.07K is the 2nd highest of the 7 companies compared; the peer median is $2.93K.
- Its year-over-year change of +105.1% is the highest of 6, against a peer median of +25.0%.
- Common stock amounts to 0.0% of total assets for MAIA, versus a peer median of 0.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $162.69K | -89.1% | -43.6% | 0.4% | |
| Mar 2026 | $6.07K | +105.1% | +52.2% | 0.0% | |
| Mar 2026 | $5K | +25.0% | +58.7% | 0.0% | |
| Dec 2025 | $3K | +50.0% | -41.5% | 0.0% | |
| Mar 2026 | $2.85K | +46.5% | +49.4% | 0.0% | |
| Mar 2026 | $1.13K | +4.4% | +911.8% | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding MAIA) | $2.93K | +25.0% | +49.4% | 0.0% | |
Competitors are the stored peer set for MAIA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 10.57M | 10.95M | 7.15M | 9.6M | 8.66B |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 43.67K | 302.79K | 144.68K | 77.35K | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | (43.67K) | 554.32K | 268.68K | 473.83K | (8.65B) |
| Total Current Assets | 10.67M | 11.81M | 7.56M | 10.15M | 9.7M |
| Property, Plant & Equipment (Net) | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 654.7K | 214K | 2.8K | 2.8K | 2.8K |
| Total Non-current Assets | 654.7K | 214K | 2.8K | 2.8K | 2.8K |
| Total Assets | 11.33M | 12.02M | 7.57M | 10.16M | 9.7M |
| Account Payables | 960.4K | 1.17M | 1.64M | 1.51M | 2.04M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 496.02K | 1.09M | 1.61M | 941.1K | 1.2M |
| Total Current Liabilities | 2.15M | 3.27M | 4.94M | 3.83M | 5.84M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 245.34K | 2.15M | 2.69M | 1.49M |
| Total Non-current Liabilities | 0 | 245.34K | 2.15M | 2.69M | 1.49M |
| Total Liabilities | 2.15M | 3.51M | 7.09M | 6.52M | 7.33M |
| Common Stock | 758 | 1.1K | 1.7K | 2.62K | 3.86K |
| Retained Earnings | (28.44M) | (44.21M) | (63.98M) | (87.23M) | (109.63M) |
| Accumulated OCI | 0 | (15.97K) | (16.26K) | (30.62K) | (50.23K) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 9.18M | 8.51M | 477.51K | 3.63M | 2.38M |
| Total Debt | 0 | 0 | 0 | 0 | 0 |
| Net Debt | (10.57M) | (10.95M) | (7.15M) | (9.6M) | (8.66B) |
MAIA Biotechnology, Inc.
AMEX:MAIA
Intrinsic Alpha fair value
Locked
Current Price
$1.30
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.